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Abstract
Purpose Calcium ions are highly versatile spacial and
temporal intracellular signals of non-excitable cells and
have an important impact on nearly every aspect of cellular
life controlling cell growth, metabolism, Xuid secretion,
information processing, transcription, apoptosis, and
motility. Neurons and glia respond to stimuli, including
neurotransmitters, neuromodulators, and hormones, which
increase the intracellular calcium concentration. The func-
tion of intracellular calcium in gliomas is unknown. Lots of
daily used drugs may act via receptors that can be linked to
the intracellular calcium system and therefore could inXu-
ence glioma biology.
Methods Glioma cells were loaded with the calcium ion
sensitive dye Fura 2-AM. Subsequently, cells were stimu-
lated with 25 diVerent medical drugs for 30 s. The increase
of free intracellular calcium ions was measured and calcu-
lated by a microscope–camera–computer-unit.
Results Except for the buVer solution HEPES that served
as negative control and for the cortisol derivative dexa-
methasone, all other 24 tested drugs induced a rise of intra-
cellular calcium ions. The cellular calcium responses were
classiWed into seven functional groups. The tested sub-
stances activated several types of calcium channels and
receptors.
Conclusions Our study impressively demonstrates that
medical drugs are potent inducers of intracellular calcium
signals. Totally unexpected, the results show a high amount
of functional cellular receptors and channels on glioma
cells, which could be responsible for certain biological
eVects like migration and cell growth. This calcium imag-
ing study proves the usability of the calcium imaging as a
screening system for functional receptors on human glioma
cells.
Keywords Glioma · Calcium imaging · Drugs · 
Cell-surface receptors · Tumor proliferation · 
Tumor invasion
Introduction
Mammalian glial cells express a broad spectrum of
neuroligand receptors and ion channels as do neurons and
other excitable cells as well (Baimbridge et al. 1992;
Bender and Hertz 1987; Bernstein et al. 1996; Bordey et al.
1994; Castillo et al. 2007; Fatatis et al. 1994; Albrecht et al.
2001; Friel 1995; Han et al. 2002; Hösli and Hösli 1987;
Hösli et al. 1984; Kirischuk et al. 1996; Möller 2002; Nielsen
et al.  1990; Sharma et al. 2001; Verkhratsky et al. 1998;
Färber and Kettenmann 2006; Verkhratsky and Shmigol
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1996; Weydt et al. 1997; Wienrich and Kettenmann 1989;
Perea and Araque 2005). These receptors are known on
glial cells as adenosine triphosphate, acetylcholine, brady-
kinin, endothelin, -aminobutyric acid, glycine, glutamate,
histamine, oxytocin, platelet-activating factor, substance P,
and many other receptors (Verkhratsky et al. 1998; Wien-
rich and Kettenmann 1989; Verkhtatsky and Steinhäuser
2000). New results show astrocytic calcium signaling to
play a pivotal role in the astrocyte–neuron interaction and
in the regulation of local cerebral blood supply in depen-
dence of neuronal activity (Perea and Araque 2005; Schi-
pke et al. 2002; Peters et al. 2003; Lovick et al. 2005;
Gordon et al. 2008; Anderson and Nedergaard 2003; Iade-
cola and Nedergaard 2007; Straub and Nelson 2007).
However, very little data exists about the expression and
the functional role of neuroligand receptors and ion chan-
nels in human glioma cells (Weydt et al. 1997; Sontheimer
2003, 2004, 2008a, b; Lyons et al. 2007; McCoy and Sont-
heimer 2007; Weaver et al. 2006; Olsen et al. 2003; Syno-
witz et al. 2001; Labrakakis et al. 1998a, b). Only a few
publications conWrm an impact of neuroligand receptors
and ion channels for glioma proliferation and migration
(Sharma et al. 2001; Sontheimer 2003,  2004,  2008a,  b;
Lyons et al. 2007; McCoy and Sontheimer 2007; Weaver
et al. 2006; Olsen et al. 2003; Synowitz et al. 2001).
Calcium ions are known to play an important role in the
regulation of cellular processes, like the regulation of gene
expression, cellular migration, metabolism, and prolifera-
tion (Perea and Araque 2005; Berridge 2008; Berridge et al.
2003; Clapham 2007; Jaiswal 2001; Parekh 2006; Parekh
and Penner 1997; Berridge et al. 2003). As a prerequisite,
the concentration of free intracellular calcium ions [Ca2+]i in
the cytosol needs to be permanently constant with less than
10¡5 M (Verkhratsky et al. 1998; Verkhtatsky and Steinhä-
user 2000). Most of the free intracellular calcium ions are
stored, for instance, in the sarcoplasmic and endoplasmic
reticulum or bound to calcium binding proteins like calbin-
din, calmodulin, and calsequestrin (Berridge et al. 2003).
After the stimulation of the cells, their intracellular free cal-
cium ions may rise to the tenfold of the basal level, which
activates a multitude of cellular reactions via the so called
calcium signaling (Verkhtatsky and Steinhäuser 2000;
Berridge et al. 2003; Parekh 2008; Barres 2008; Iino 2008).
Calcium signals are caused by the interaction of several
mechanisms like the inXux of calcium ions through the cel-
lular membrane into the cell caused by an electrochemical
gradient. In addition to that, calcium ions can be released
from intracellular stores into the cytoplasm (Verkhtatsky
and Steinhäuser 2000; Parekh 2008; Blaustein and Golovina
2001). A calcium outXow into the extracellular compart-
ment and into the intracellular stores lowers the increased
intracellular calcium ion concentration and enables the
maintenance of the low basal level.
The inXux of calcium ions into the cytoplasm across the
cell membrane involves calcium permeable ion channels.
The cellular membrane contains voltage-gated calcium chan-
nels (VGCC) that open, when action potentials are generated
and cause a depolarization of the cellular membrane, recep-
tor-operated calcium channels (ROCs) which are regulated
by ligand binding, and store-operated calcium channels
(SOCs) that are activated by a calcium release from intracel-
lular stores like the endo- or sarcoplasmic reticulum (Verkh-
tatsky and Steinhäuser 2000; Blaustein and Golovina 2001).
The store-operated calcium channels cause an inXux of cal-
cium ions from the cytoplasm into the empty intracellular
stores. The calcium ion release from intracellular stores is
mainly regulated by the second messenger inositol-1,4,5-tris-
phosphate (IP3)-sensitive calcium channels (Verkhratsky
et al.  1998; Verkhtatsky and Steinhäuser 2000; Berridge
2008; Parekh 2006; Parekh and Penner 1997; Blaustein and
Golovina 2001; Putney 2007; Putney 1997). IP3 is produced
after the stimulation of G-protein coupled neuroligand
Fig. 1 Prerequisites of calcium imaging (a–e) and types of cellular
calcium responses (f–j). a Chemical structure of the calcium ion sen-
sitive compound Fura-2 AM in its ester version. After diVusion of
Fura-2 AM into the cell, esterases cleave the esther bond and prevent
the Fura’s diVusion out of the cell. b Fundamental equation for the
evaluation of the ratio of the frequencies at wavelengths of 340 and
380 nm. c Photography of a calcium imaging set up with the micro-
scope-camera-computer-unit.  d The calcium-sensitive dye Fura-2
changes its excitation wavelength upon the binding of calcium ions.
The more calcium ions are within the cytoplasm, the more calcium
ions are bound by Fura-2. The shift of the wavelength is recognized by
the camera and saved by the computer. The higher the intracellular cal-
cium concentration is, the more shifts the color of the cells to green,
yellow, or red. e Regions of interest (ROIs) can be deWned in distinct
cells. The color shift is calculated by the computer and translated into
a ration curve in dependence on the time. f–j Distinct types of intracel-
lular calcium responses without intermediate states (modiWed from
Möller (2002)). f This type of calcium signal is characterized by its
transient nature with a fast initial rise and a rapid falling component.
Opening of intracellular stores and/or transiently open cell membrane
channels cause an inXux of free calcium ions into the cell. Free cal-
cium ions subsequently are cleared from the cytoplasm. ATP-depen-
dent Ca2+ pumps transport the calcium ions into the intracellular stores
and into the extracellular compartment. Calcium signals that resemble
this course are considered type 1 in our study. g This type of transient
calcium signal is caused by and initial maximum calcium concentra-
tion followed by a plateau. The signal results from an initial inXux of
calcium ions from intracellular stores and/or from the extracellular
compartment via cell membrane channels. This is followed by a slower
calcium inXux via receptor-operated calcium channels or store-
operated calcium channels. Free calcium ions are cleared thereafter
from the cytoplasm by ATP-dependent calcium pumps to maintain the
non-toxic basal level. Calcium responses that resemble this signal are
considered type 2. h This type of calcium signal is characterized by
repeated oscillations that are caused by a complex interaction between
calcium release from intracellular stores and calcium inXux through
open store-operated channels. Calcium responses of this form are con-
sidered type 3. j A slowly rising intracellular calcium ion level is
mostly caused by a very slowly increasing calcium conductibility of
the cellular membrane or a modulation of calcium extrusion mecha-
nisms. Signals that are similar to this course are summarized as type 4
J Cancer Res Clin Oncol (2009) 135:1729–1745 1731
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receptors after activation of phospholipase C via trimere
G-proteins (Verkhratsky et al. 1998; Verkhtatsky and
Steinhäuser 2000; Berridge 2008; Parekh 2006; Parekh and
Penner  1997; Blaustein and Golovina 2001; Putney 2007;
Putney 1997). The opening of IP3 sensitive calcium channels
may be strengened by cytoplasmic calcium ions, thereby
causing a further induction of calcium release. This
phenomenon is called calcium induced calcium release
(CICR) (Verkhratsky et al. 1998; Verkhtatsky and Steinhäuser
2000; Berridge 2008; Parekh 2006; Parekh and Penner 1997;
Blaustein and Golovina 2001; Putney 2007; Putney 1997).
Additionally, the activation of ryanodine receptors may
increase the calcium release from intracellular stores into
the cytoplasm. (Berridge et al. 2003; Blaustein and
Golovina  2001; Matyash et al. 2002; Bardo et al. 2006).
Neurons and astrocytes express ryanodine receptors
(Matyash et al. 2002; Bardo et al. 2006). Whether glioma
cells carry ryanodine receptors is not yet known. Adenosine
triphosphat activated calcium pumps (Ca2+-ATPases) in the
cellular membrane and in the membranes of intracellular
calcium stores transfer free calcium ions, which are toxic
for the cell, out of the cytoplasm into the extracellular
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compartment or into the endo- or sarcoplasmic reticulum
against the electrochemical gradient.
All these mechanisms regulate the important ion cal-
cium. The expression of receptors and ion channels linked
to intracellular calcium ion signaling have been shown for
all types of glial cells in vitro as well as in situ and for
diVerent groups of neurons. The amplitude and kinetics of a
calcium ion signal is determined by pharmacological fea-
tures of the neuroligand receptor, the ion channel, and the
parameters of its cytosolic calcium eVector cascade. The
release of calcium ions from inositol-1,4,5-triphopshate or
ryanodine-sensitive intracellular calcium stores, the status
of calcium release-activated calcium channels, and the
eYcacy of the calcium-buVering systems are signiWcant ter-
minators of the calcium response.
In the present study, human glioma cells were tested for
their ability to raise the intracellular free calcium ion con-
centration upon stimulation of neuroligand receptors or ion
channels via daily used medical drugs. Calcium imaging
was used as a screening method to detect receptor mecha-
nisms that could inXuence glioma biology signiWcantly.
Materials and methods
Cell culture
Human glioma cell lines U373MG and U87MG were cul-
tured for 5–10 days in Dulbecco’s ModiWed Eagle Medium
(DMEM) with the supplement of 10% fetal calf serum
(FCS) at a temperature of 37°C, 5% carbon dioxide, 95%
oxygen, and 95% humidity. Prior to measurements, cells
were seeded on glass coverslips at a density of 1 £ 104 cells
and allowed to adapt for 24 h.
Calcium measurements via “Calcium Imaging”
All experiments were performed at least in triplicate under
permanent perfusion with HEPES buVer made from NaCl
(150 mM), KCl (5.4 mM), CaCl2 (2 mM), MgCl2 (1 mM),
HEPES/NaOH (10 mM), and glucose (10 mM) at a pH of
7.35 at room temperature.
The “Calcium Imaging” is an imaging procedure, which
measures the concentration of free intracellular calcium
Table 1 Summary of all tested 26 substances including their used dosage and their producing companies
Medical preparation Dosage/amount Purchased from
(1) Histamine 100 M Sigma Aldrich Taufkirchen Germany
(2) Substance P 100 M Sigma Aldrich Taufkirchen Germany
(3) Vasoactive intestinal polypeptide 100 M Sigma Aldrich Taufkirchen Germany
(4) Neurokinin A 100 M, 10 M Sigma Aldrich Taufkirchen Germany
(5) Neurokinin B 10 M Sigma Aldrich Taufkirchen Germany
(6) Potassium ions 1 M Fresenius SE Bad Homburg Germany
(7) Calcium ions 1 M Sandoz Pharmaceuticals GmbH Holzkirchen Germany
(8) Sodium ions 1 M Fresenius SE Bad Homburg Germany
(9) Dexamethasone 4 mg Merck KGaA Darmstadt Germany
(10) Clonidine 0.15 mg AWD.pharma GmbH & Co. KG Radebeul Germany
(11) Theophylline 20 mg Altana Pharma Deutschland GmbH Konstanz Germany
(12) Droperidol 1.25 mg Janssen Pharmaceutica Beerse Belgium
(13) Metamizol 50 mg Rationpharm GmbH Ulm Germany
(14) Cafedrin/theodrenalin (combi) 100 mg/5 mg (combi) AWD.pharma GmbH & Co. KG Radebeul Germany
(15) Promethazine 25 mg Bayer Vital GmbH Leverkusen Germany
(16) Diazepam 5 mg Rationpharm GmbH Ulm Germany
(17) Hydrocortisone 5 mg Teopharma Valle Salimbene Italy
(18) Thiamazole 4 mg Temmler Pharma GmbH & Co. KG Marburg Germany
(19) Physostigmin 0.4 mg Dr. F. Köhler Chemie Alsbach-Hähnlein Germany
(20) Haloperidol 5 mg Rationpharm GmbH Ulm Germany
(21) Phenytoin 10 mg Desitin Arzneimittel GmbH Hamburg Germany
(22) Epinephrine 1 mg Jenapharm GmbH & Co. KG Jena Germany
(23) Urapidil 5 mg Altana Pharma Deutschland GmbH Konstanz Germany
(24) Metoclopramide 5 mg Hexal AG Holzkirchen Germany
(25) Dimetindene 1 mg Novartis Consumer Health GmbH München Germany
(26) HEPES buVer Components see text Sigma Aldrich Taufkirchen GermanyJ Cancer Res Clin Oncol (2009) 135:1729–1745 1733
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ions ([Ca2+]i) or their dynamic changes by Xuometry.
[Ca2+]i was monitored using the calcium-sensitive Xuores-
cent indicator fura-2 acetoxy methyl ester (fura-2 AM)
from Molecular Probes (Eugene, Oregon, USA). Fura-2
AM permeates through the cellular membrane and looses
its ester bond by hydrolysis, which causes the generation of
its acidic form (Fig. 1). This acid (fura-2) does not diVuse
out of the cell and speciWcally binds free calcium ions. By
binding calcium ions, fura-2 changes its speciWc wave
length and frequency. This change can be measured and
calculated (Fig. 1). Cells were loaded with fura-2 AM
(5 M; stock solution in DMSO) by incubation in bathing
solution for 30 min at 37°C within the incubator. Subse-
quently, cells were superfused with HEPES buVer, and
images were taken every 3 s. After 15 s, cells were stimu-
lated with 25 diVerent drugs for 30 s and the HEPES buVer
solution as a negative control (Table 1). For fura-2 excita-
tion, cells were illuminated at two alternating wavelengths,
340 § 5 and 380 § 5 nm, respectively (Fig. 1). Excitation
was performed by a monochromator (Polychrome IV;
T.I.L.L. Photonics, Martinsried, Germany). The emitted
light was collected at 530 § 10 nm by the long-term expo-
sure CCD camera QuantiCam Long Exposure VGA-b/w
(Phase, Luebeck, Germany) coupled to a Zeiss Axioskop
(Oberkochen, Germany) equipped with a 20£ water
immersion Zeiss objective with a numerical aperture of 0.5
(Fig. 1). The monochromator and CCD camera were con-
trolled by TILL Photonics software TILLvisION (TILL
Photonics, GraefelWng, Germany), being also used for
image processing. Data analysis was performed after the
deWnition of a region of interest (ROI) with standard per-
sonal computer software. The [Ca2+]i was calculated from
the ratio (R) of Xuorescence recorded at 340 and 380 nm
excitation wavelengths (Fig. 1). In all experiments, the
basal calcium level within the cytoplasm before the stimu-
lation with the 25 diVerent substances was measured at the
ratio (R = F340/380) between 0.3 and 0.5 that was in con-
cordance with a typical ratio for viable resting cells
(Fig. 1). According to the shape of the resulting transient
calcium signal, cellular responses were classiWed into dis-
tinct types (Fig. 1).
Results
ClassiWcation of intracellular calcium responses into seven 
types
According to our knowledge about the shape and course of
transient intracellular calcium ion increases, we classiWed
the reaction of our cells to the substituted medical drugs
into seven types (Table 2) (Möller 2002). The calcium sig-
nals of the groups 1–4 are called signals of the types 1–4.
Group 5 consists of medical drugs that caused calcium
raises, similar to a mixed type 3 and 4. Group 6 consists of
ion preparations; the according calcium signals are called
Table 2 Groups of drugs are correlated to their appropriate type of elicited calcium signal
Sketches of calcium signals are used to illustrate the groups according to the sketches in Fig. 1. All substances of every group eliciting their speciWc
calcium response are listed. The combined drug made from cafedrin and theodrenalin is sorted into group 2 and group 4 according to the shape of
the calcium response and according to the supposed calcium signals elicited by both substances in single preparations
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Group 7
potassium HEPES
buffer
phenytoin thiamazole hydrocortisone metamizol theophyllin calcium dexa-
methasone
vasoactive
intestinal
polypeptide (VIP)
cafedrin/theo-
drenalin (combi)
neurokinin A promethazine
dimetindene neurokinin B diazepam
physostigmin
cafedrin/theo-
drenalin (combi)
epinephrine
mixed type
3 and 4  „ion type“ no signal  type 1 signal  type 3 signal  type 4 signal  type 2 signal 
haloperidol histamine metoclopramide clonidine subtance P
urapidil  sodium
droperidol1734 J Cancer Res Clin Oncol (2009) 135:1729–1745
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“ion type” signals. The only substances those did not elicit
a calcium response are summarized into group 7.
Calcium signals of type 1
Group 1 was formed by substances that established a fast
initial increase of free intracellular calcium ions with a
rapid falling component. The opening of intracellular stores
and/or transiently open cell membrane channels can cause
an inXux of free calcium ions that resembles the trace in
Fig. 1f (Möller 2002). Calcium responses that resemble this
course are considered type 1 in our study. The included
substances are: haloperidol, urapidil, droperidol, dimetind-
ene, and phenytoin, (Table 2, Figs. 1, 2).
Haloperidol, urapidil, dimetindene, droperidol, and phe-
nytoin caused intracellular calcium signals to raise and fall
quickly and sharply. In summary, 182 cells of all 189 tested
U87MG glioblastoma cells and 30 of the 42 tested
U373MG cells showed the type 1 calcium response
(Fig. 2).
Fig. 2 Substances of group 1 
that elicit type 1 calcium signals. 
The table indicates the positive 
cells out of all tested cells for 
every medical drug. The num-
bers in brackets indicate the 
positively tested cells in every 
single experiment. a–c The 
graphics below depict the 
courses of the calcium signals 
after administration of phenyt-
oin, dimetindene, and droperidol 
to the human glioma cells in 
typical experimental settings. 
The bars indicate the duration 
of substance administration 
according to the details 
mentioned in “Methods”
11/19 ll (4 6 9) 21/21 ll (8 4 9) Ph t i
19/23 cells (10+7+6) 67/68 cells (24+19+25) Haloperidol
Positive calcium 
signal in U373MG cells
Positive calcium 
signal in U87MG cells
Substances of group 1
not tested 25/29 cells (14+8+7) Dimetindene
not tested 39/39 cells (13+12+14) Droperidol
not tested 30/32 cells (15+7+10) Urapidil
11/19 cells (4+6+9) 21/21 cells (8+4+9) Phenytoin
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Calcium signals of type 2
Group 2 was formed by the medical drugs that, when
applied, resulted in a transient calcium signal with a slow
initial maximum followed by a plateau phase. The calcium
answer represents a mixed type of calcium ion increase
within the cytoplasm. This results from an initial inXux of
calcium ions from intracellular stores and/or from the extra-
cellular compartment. This is then followed by a calcium
Xow via receptor operated calcium channels or store operated
calcium channels (Möller 2002). This group consists of
substance P, vasoactive intestinal polypeptide, neurokinin
A, neurokinin B, physostigmine, epinephrine, and thiamazole.
The combination from cafedrine and theodrenalin causes a
mixed calcium ion signal composed of type 2 and type 4 of
calcium signals (Table 2, Figs. 1, 3).
Substance P, vasoactive intestinal polypeptide, neu-
rokinin A, neurokinin B, thiamazole, physostigmin, and
epinephrine were administered to the cultured human
glioblastoma cells. The calcium response is characterized
Fig. 3 Substances of group 2 
that induce type 2 calcium sig-
nals with a typical “calcium 
shoulder” are illustrated. The 
table indicates the positive cells 
from all tested cells. a–c The 
graphics below show the cal-
cium responses from typical 
experiments upon the stimula-
tion with neurokinin A, neuroki-
nin B, and substance P. The bars 
indicate the duration of sub-
stance administration according 
to the details mentioned in 
“Methods”
21/21 cells (6+9+6) 61/61 cells (15+22+24) VIP
63/63 cells (29+22+12) 70/81 cells (30+33+18) Substance P
Positive calcium signal in 
U373MG cells
Positive calcium signal in 
U87MG cells
Substances of group 2
tt t d 41/41 ll (14 14 13) C f d i /Th d li
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by the typical fast rise of the intracellular free calcium ions
being followed by a long-lasting plateau phase, also called
“calcium shoulder”. After this plateau, the intracellular
concentration of free calcium ions slowly returned to the
cellular basal calcium level (Fig. 3). Three hundred and
seventy-nine cells of the U373MG cells (n = 403) and 268
cells of the U87MG cells (n = 277) showed a postive cal-
cium response upon exposure of the diVerent substances
(Fig. 3).
Calcium signals of type 3
Group 3 consists of substances that cause intracellular cal-
cium oscillations. These calcium oscillations result from a
complex interaction between calcium inXux mechanisms,
via calcium release from internal stores or open store operated
calcium channels, and calcium outXux processes, which
reWll the intracellular stores and transport calcium ions into
the extracellular milieu (Möller 2002). Histamine and
hydrocortisone caused this type of calcium signal in our
glioblastoma cells (Table 2, Fig. 1, 4).
The stimulation of the glioma cells with histamine and
hydrocortisone elicited oscillating increases of free intra-
cellular calcium ions. The cells showed a fast increase of
intracellular calcium that was undulant on a kind of a pla-
teau in a very typical manner and could be reproduced sev-
eral times (Fig. 4). In summary, 129 cells of the U87MG
and the U373MG human glioblastoma cell lines were tested
with histamine and 72 cells of these two cell lines were
tested for their response upon hydrocortisone stimulation.
One hundred percent of the tested cells displayed the
described calcium response (Fig. 4).
Fig. 4 The drugs of group 3 
elicit typical type 3 calcium sig-
nals with the characteristic cal-
cium oscillations. Histamine and 
hydrocortisone belong to this 
group of substances. a–c The 
graphics below show the cal-
cium oscillations upon the single 
of twofold administration of his-
tamine and hydrocortisone, 
respectively. The bars indicate 
the duration of substance admin-
istration according to the details 
mentioned in “Methods”
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Positive calcium signal in 
U373MG cells
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Calcium signals of type 4
The type 4 calcium signal of the group 4 drugs is character-
ized by a slowly increasing intracellular concentration of
free calcium ions (Table 2, Fig. 1, 5). This slowly rising
intracellular calcium ion level is caused by a very slow
increase of conductibility of the cellular membrane or a
modulation of calcium extrusion mechanisms (Möller
2002). Substances of group 4 are metoclopramide,
metamizol, promethazine, and diazepam. The combination
of cafedrin and theodrenalin shows components of a type 2
response and a type 4 response. Two hundred and eight
Fig. 5 Drugs of group 4 that 
cause decelerated calcium in-
creases are summarized. The ta-
ble shows the drugs and the 
number of cells tested positively 
out of the total number of tested 
cells. a–c The graphics below 
demonstrate typical experimen-
tal results upon the exposure of 
promethazine, diazepam, and 
metamizol to the human glio-
blastoma cells. The bars indicate 
the duration of substance admin-
istration according to the details 
mentioned in “Methods”
not tested 57/57 cells (22+17+18) Metamizol
not tested 25/48 cells (17+13+18) Metoclopramide
Positive calcium 
signal in U373MG 
cells
Positive calcium 
signal in U87MG cells
Substances of group 4
Application of promethazine to human glioma cells A
not tested 41/41 cells (14+14+13) cafedrin/theodrenalin (combi)
16/27 cells (8+10+9) 45/45 cells (14+16+15) Diazepam
18/18 cells (4+6+8) 40/43 cells (7+21+15) Promethazine
not tested 57/57 cells (22+17+18) Metamizol
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cells of the tested U87MG cells (n = 234) and 34 cells of
the tested U343MG (n = 45) repeatedly showed a positive
response resembling the type 4 signal (Fig. 1, 5).
Calcium answers with features of type 3 and type 4 signals
Group 5 contains the drugs clonidine and theophylline. In our
glioblastoma cells, the calcium responses could not be classi-
Wed into groups 1 through 4 because the calcium signal was
of a mixed type 3 and 4. This was repeatedly shown in our
experiments with the U373MG and the U87MG glioblas-
toma cells (Table 2, Fig. 1, 6). Fourty six cells of the U87MG
line were tested with theophylline and showed a positive
response (Fig. 6). Thirty-Wve U87MG cells were investigated
upon the administration of clonidine to the perfusing bath
solution; 32 of these showed the positive reaction (Fig. 6).
Eleven cells from 16 tested U373MG cells reacted in the
same manner to the application of clonidine (Fig. 6).
Group 6 of substances
Into group 6, all the ion preparations with an increase of the
intracellular calcium level by administration of free ion
solutions were included. The resulting calcium signal was
called “ion type” signal irrespective of the mechanisms
responsible for the signal (Table 2). The application of
extracellular calcium caused the intracellular stores to be
reWlled, accompanied by a transient increase of cytosolic
free calcium ions (Fig. 7). The application of potassium ions
caused a membrane depolarization, thereby causing extra-
cellular calcium ions to pass through voltage-gated calcium
channels and again transiently increasing the concentration
of intracellular free calcium ions (Fig. 7). The sodium ions
passed from the extra- to the intracellular compartment and
were exchanged by calcium ions during the clearance pro-
cess (Fig. 7). All cells of the two glioblastoma cell lines
showed the above mentioned cellular responses (Fig. 7).
Negative control with HEPES buVer and dexamethasone
Into group 7, the non-reactive substances, the negative con-
trol HEPES and the cortisol derivative dexamethasone were
included (Table 2, Fig. 8).
As was expected, the negative control with the applica-
tion of the isotonic HEPES buVer itself did not cause any
change of the intracellular calcium ion baseline. Thirty-seven
Fig. 6 Theophylline and cloni-
dine were deWned as group 5 of 
medical drugs according to the 
appearance of their calcium sig-
nal that resembles the signals of 
groups 3 and 4. The table shows 
the tested substances. a, b The 
graphics show the delayed start 
of the intracellular calcium rise 
and the grafted calcium oscilla-
tions. The bars indicate the dura-
tion of substance administration 
according to the details men-
tioned in “Methods”
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cells of the U87MG glioblastoma cell line and 29 cells of
the U373MG glioblastoma cell line were tested in three
independent experiments (Fig. 8). In accordance with that,
the application of dexamethasone did not result in any rise
or decline of the intracellular calcium level. Fourty three
cells of the U87MG glioblastoma cell line and 23 cells of
the U373MG glioblastoma cell line were tested (Fig. 8).
Discussion
Calcium ions are a highly versatile intracellular signal that
acts as a means of information proceeding within the cell’s
cytoplasm to regulate many diVerent cellular processes, like
cellular metabolism, gene transcription, proliferation, or
cellular movement (Fig. 9) (Bernstein et al. 1996; Fatatis
et al.  1994; Friel 1995; Möller 2002; Verkhratsky et al.
1998; Färber and Kettenmann 2006; Verkhratsky and
Shmigol 1996; Perea and Araque 2005; Verkhtatsky and
Steinhäuser 2000; Berridge et al. 2003).
Fast intracellular calcium peaks regulate fast reactions
(Berridge et al. 2003). Slower calcium increases are
involved in prolonged signaling chains. Calcium increases
are regulated by a complex network of mechaisms. These
include the inXux from the extracellular space via voltage-
gated calcium channels of the cellular membrane. G-protein
coupled receptors can increase the cytoplasmic calcium con-
centration by release of calcium ions from intracellular
stores via store operated calcium channels. Receptor oper-
ated calcium channels may cause the inXux of calcium ions
from the extracellular space or from intracellular stores
(Fig. 9) (Berridge et al. 2003). After initialization of intra-
cellular down-stream processes free intracellular calcium
ions are toxic to the cell. Therefore, the cell has mechanisms
of calcium clearance to reduce the calcium concentration
down to a non-toxic level. Calcium ions are transported out
of the cell or into the intracellular calcium stores by Ca2+-
ATPases (Fig. 9). Other ion pumps and exchangers of cellu-
lar membranes, like the Na+–Ca2+-exchanger, the H+–Ca2+-
exchanger, or the NA+–K+-ATPase support the maintenance
of the intracellular ion milieu (Fig. 9).
Neurons and glial cells are known for the crouded expres-
sion of cell surface ion channels and neurotransmitter recep-
tors that regulate the intracellular calcium level in order to
regulate the activation of the complex down-stream processes
(Albrecht et al. 2001; Verkhratsky and Shmigol 1996).
This publication describes for the Wrst time a fast and
eYcient screening system to evaluate the expression of ion
channels and neurotransmitter receptors on human glioma
cells that are linked to the intracellular calcium signaling
mechanisms.
Patients with human glioblastomas mostly belong to the
elder population according to the epidemiological proWle of
the disease. They get many diVerent drugs for the treatment
of high blood pressure, heart disease, kidney dysfunction,
and more. They receive the drug dexamethasone for the
reduction of the peritumoral brain edema. Especially older
patients may suVer from some mental confusion that some-
times requires the administration of sedative drugs.
Depending on the multitude of cerebral signaling pathways,
one can imagine an eVect of medical drugs on glioma biology
in case the tumor would express any of the responsible
receptors or ion channels.
Human glioma cells are known to express receptors for
neurokinins, VIP, and substance P (Bordey et al. 1994;
Nielsen et al. 1990; Sharma et al. 2001; Sokolowska and
Nowak  2008; Cooper et al. 1988; Luo et al. 1996;
Grynkiewicz et al. 1985; Eistetter et al. 1992; Gazarczyk
et al. 2007). This was shown in our experiments as well and
could serve as positive control for the induction of intracel-
lular calcium signals. Another study showed human glioma
cells to express cell-surface receptors for angiotensin II,
bradykinin, histamine, substance P, norepinephrine, and
serotonin (Weydt et al. 1997).
The HEPES buVer solution corresponds to the extracel-
lular Xuid within the CNS. This means, HEPES has to be
electroneutral without any activation of intracellular down-
stream events upon cellular exposure. This was proved by
our experiments as well. Twenty-Wve medical drugs were
tested for their ability to elicit intracellular calcium signals
in human glioma cells. Most of the drugs are known to acti-
vate distinct cell-surface receptors or ion channels. We
found all drugs expect for one to elicit intracellular calcium
answers (Table 2). According to the anticipated involved
calcium pathways, the intracellular calcium responses were
summarized into seven types and the responsible drugs
were organized into seven groups. Type 1 of calcium sig-
nals is elicited by haloperidol, urapidil, droperidol, dimet-
indene, and phenytoin. Haloperidol blocks dopamine
receptors as well as muscarinic receptors and adrenergic
receptors. Droperidol, another neurolepticum, binds to D2
dopamine receptors and with a lower aYnity to D3 dopa-
mine receptors, 5-HT 2 receptors, and alpha-1-adrenore-
ceptors, whereas dimetindene binds H1 histamine
receptors. Alpha-1-adrenoreceptors are G-protein coupled
receptors and cause in intracellular calcium ion increase via
the G-protein-inositol-1,4,5-triphosphate-cascade (Fig. 9).
The putative pathways of calcium signaling induction by
these drugs currently are not known and require further
research. Urapidil blocks alpha-1-adrenoreceptors but
stimulates central 5-hydroxytryptamine 1A (5-HT 1A) recep-
tors. Serotonin receptors can activate inwardly or outwardly
rectifying potassium currents as was shown for neurons of
the substantia gelatinosa (Abe et al. 2009). These currents
can change the cellular membrane potential and thereby
activate voltage-gated calcium channels for a calcium1740 J Cancer Res Clin Oncol (2009) 135:1729–1745
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inXux into the cell. To the voltage-gated calcium channels
belong the L-type calcium channels (CaV1.1, CaV1.2,
CaV1.3, CaV1.4), the P/Q-type calcium channels (CaV2.1),
the N-type calcium channels (CaV2.2), the R-type calcium
channels (CaV2.3), and the T-type calcium channels
(CaV3.1, CaV3.2, CaV3.3) (Berridge et al. 2003). Which of
these channels are activated and what their activation
induces in the glioma cell, has to be determined in the
future. The calcium signal caused by all of these drugs is
characterized by its transient nature with a fast initial rise
and a rapid falling component. Transiently open intracellu-
lar stores and/or open cell membrane channels cause this
rapid intracellular response. Down-stream processes are
initiated quickly. The exact nature of these processes within
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cells
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human glioma cells is not known yet and is subject of ongo-
ing research. The high concentration of free intracellular
calcium ions is cleared immediately from the cytoplasm by
a complex network of mechanisms (Fig. 9). Substances that
cause type 2 calcium responses are summarized in Table 2.
Whereas substance P, vasoactive intestinal polypeptide,
and the neurokinins A, and B are known to inXuence gli-
oma biology (Bordey et al. 1994; Sokolowska and Nowak
2008; Cooper et al. 1988; Luo et al. 1996; Eistetter et al.
1992;  Gazarczyk et al. 2007), thiamazole, physostigmin,
and epinephrine were not known to elicit calcium signals in
human glioma cells or to inXuence their proliferation or
migration. Calcium signals in a former study were not clas-
siWed into groups, but the calcium signal induced by nor-
epinephrine was similar to our signal elicited by
epinephrine (Weydt et al. 1997). The combined preparation
of cafedrin and theodrenalin induces a signal with a fast ini-
tial rise and the typical “calcium shoulder” like in type 2
calcium signals that is merged to a “calcium tail” typical for
type 4 calcium responses. The combined drug is used
amongst others during anesthesia to control the blood pres-
sure. As our results clearly demonstrate, this drug acts onto
several calcium signaling pathways and could have several
eVects on human glioblastoma cells. Physostigmin stimu-
lated both, nicotinic and muscarinic receptors. Muscarinic
receptors M1–M3 belong to the group of G-protein coupled
receptors like the substance P receptor NK3 (Berridge et al.
2003). Their signals are transduced by a variety of G-pro-
teins, like Gq, G11, G14, G16, and G, followed by the
activation of distinct phospholipases type C (Berridge et al.
2003). The calcium signal induced by this group of sub-
stances results from an initial inXux of calcium ions from
intracellular stores and/or from the extracellular medium
via cell membrane channels. This is followed by a slower
inXux mediated by receptor operated calcium channels or
store operated calcium channels.
Very characteristic oscillating calcium responses were
elicited by the administration of histamine and hydrocorti-
sone to our human glioblastoma cells U373MG and
U87MG. This was known to occur in vascular endothelial
cells upon the exposure of histamine (Zhu et al. 2008;
Barajas et al. 2008; Lefranc et al. 2006; Hernández-Angeles
et al.  2001). Also neurons can show oscillations of the
intracellular calcium level after the administration of hista-
mine (Hegedus et al. 2004). Steroid hormones are known
for their eVect on the activity of calcium-activated potas-
sium channels (Chang and Zhang 2008), but it was not
known that they could induce calcium responses. Cortisol
was shown to suppress voltage-gated calcium channels in
prolactin cells of the tilapia (Hyde et al. 2004). In our
experiments, hydrocortisone repeatedly elicited the above
mentiomed calcium oscillations in a very stringent manner.
Glucocorticoids have been shown to stimulate the sodium
channel expression in astrocytes (Yarowsky et al. 1994).
They could have similar eVects on human glioma cells.
Their exact function is unknown to date.
The so called “ion type” of calcium signals was deWned
by the applied substance consisting of an ion solution like a
sodium ion solution, a potassium ion solution, or a calcium
ion solution. According to the glioblastoma cells’ individual
condition, some cells reacted with an intracellular calcium
signal and some cells did not. The mechanisms of calcium
rise within the cytoplasm were very diVerent for every ion
type. The extracellular exposure of a high molar calcium
solution causes the free calcium ions to diVuse along the
electrochemical concentration gradient into the cells
(Fig. 7, 9). The manner of the intracellular calcium uptake
is characterized by the cells’ condition prior to the calcium
administration. This explains the very diVerent course of
individual intracellular calcium increases, seen in Fig. 7a.
Some cells showed a strong and immediate calcium uptake
and some cells reacted twice after an interposed calcium
clearance. Other cells reacted with a delay in comparison to
strongly reacting cells. But despite diVerent calcium uptake
features, all cells showed a subsequent decrease in cyto-
plasmic calcium ions that was caused by the transport of the
ions into intracellular calcium stores or into the extracellu-
lar space. The mechanism of the calcium increase upon the
Fig. 7 All ion solutions are summarized into group 6 because of their
ionic properties irrespective of the putative mechanism of intracellular
calcium rise. The table above indicates an intracellular calcium ncrease
upon the application of either ion solution. a1, a2 As explained within
the discussion section, an extracellular calcium solution causes the
diVusion of calcium ions into the cells towards the concentration gra-
dient. Upon intracellular arrival of calcium ions, cellular mechanisms
work towards the maintenance of the low non-toxic basal calcium lev-
el. ATP-dependent Ca2+-pumps transport the calcium ions into the
intracellular stores or into the extracellular compartment. a1 The whole
course of the calcium signal is illustrated. a2 The magniWcation of A1
demonstrates the diVerent levels of intracellular calcium rise in depen-
dence on the individual status of the cell. The bars indicate the duration
of substance administration according to the details of the methods sec-
tion. b1, b2 A highly extracellular concentration of potassium ions
causes a depolarization of the cellular membrane, which is followed
subsequently by a calcium ion inXux through voltage dependent cal-
cium channels. The subsequent calcium ion clearance mechanisms
function as mentioned before by activation of the ATP-dependent cal-
cium pumps. b2 The magniWcation of b1 shows the individual levels
of the intracellular calcium increase. The bars indicate the duration of
substance administration according to the details of the methods sec-
tion. c1, c2 The administration of a highly concentrated sodium solu-
tion causes the inXux of sodium ions into the cell down the
concentration gradient. A high intracellular sodium concentration is
toxic to the cells as well. Therefore, the cells use the sodium–calcium
exchanger (Na+–Ca2+-exchanger) to remove additional sodium ions
from the intracellular compartment by exchange with extracellular cal-
cium ions. This causes a rise of intracellular calcium ions that are
cleared again by ATP-dependent calcium pumps. The bars indicate the
duration of substance administration according to the details men-
tioned in “Methods”
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exposure of potassium ions diVered signiWcantly from the
mechanisms upon calcium ion application. High molar
potassium ion solutions cause a membrane depolarization
in human glial and human glioma cells as was shown sev-
eral times before (Fig. 9) (Bernstein et al. 1996; Labrakakis
et al.  1998a,  b; Kettenmann et al. 1984). The extent of
membrane depolarization in a cell culture or in cells of an
acute brain slice swings around the Gaussian distribution.
Our experiments showed very clearly, all cells reacted with
an inXux of calcium ions via voltage-gated calcium chan-
nels with a diVerent amplitude in distinct cells (Fig. 7b, 9).
Another mechanism is responsible for the intracellular cal-
cium increase upon the exposure of a high molar sodium
ion solution. In our study, the sodium solution was hyperm-
olar in comparison to the sodium ion concentration of the
cytoplasm. This caused an inXux of sodium ions into the
cell along the concentration gradient as was known for
calcium ions as well. Fourty-three cells of our tested 50
U87MG glioblastoma cells showed this eVect. To decrease
the intracellular sodium content, the cells use sodium
pumps and sodium exchangers. The sodium–calcium
exchanger (Na+–Ca2+-exchanger) is the most common and
best known member of this family. By the transportation of
sodium ions out of the cell into the extracellular Xuid, the
cell takes up calcium ions from extracellular. This tempo-
rarily increases the intracellular calcium concentration.
These ions will be transported secondarily into intracellular
stores or into the extracellular Xuid by ATP-dependent
calcium pumps to maintain the non-toxic calcium level
after the initialization of down-stream processes (Fig. 9).
These complex mechanisms enable the cell, to maintain its
free ion content upon the eventual increase in the extracel-
lular milieu.
The presented screening procedure enables the identiW-
cation of many cellular receptors and ion channels on
human glioma cells. All of the tested substances have
receptors or ion channels on glioma cells except for the
drug dexamethasone.
Despite this surprising result, we thought initially that
glioma cells would express only a small subset of receptors
on their surfaces, but exactly the opposite proved true.
Whether all of these receptors have an supportive or inhibi-
tory eVect on glioma proliferation and glioma invasion is
not known to date. But further experiments concentrating
on each of these systems will solve this question in the
future.
Fig. 8 Group 7 consists of the 
negative control solution 
HEPES and the drug dexameth-
asone. Both substances were not 
able to induce any calcium sig-
nals as is visualized in the table 
and in the two graphics (a,b) 
below. The numbers in brackets 
within the table show the num-
ber of cells tested in summary. 
The bars indicate the duration of 
substance administration 
according to the details men-
tioned in “Methods”
0/23 cells (10+4+9) 0/43 cells (16+14+13) Dexamethasone
0/29 cells (8+9+12) 0/37 cells (16+12+9) HEPES buffer
Positive calcium 
signal in U373MG cells
Positive calcium 
signal in U87MG cells
Substances of group 7
0,2
0,3
0,4
3
4
0
n
m
/
3
8
0
n
m
)
Application of HEPES buffer to human glioma cells A
0
0,1
0 50 100 150 200 250 300
R
a
t
i
o
 
(
3
Al it i f d t h t h l i l l
time (sec)
0,1
0,15
0,2
0,25
0,3
0,35
0,4
i
o
 
(
3
4
0
n
m
/
3
8
0
n
m
)
Application of dexamethasone to human glioma cells B
0
0,05
,
0 50 100 150 200 250 300
R
a
t
i
time (sec)J Cancer Res Clin Oncol (2009) 135:1729–1745 1743
123
Acknowledgments This work was supported by LUBOM Thuringia
of the Ministry for Science, Research, and Art (2005) and by the Trust
of Neurosurgical Research of the German Society of Neurosurgery to
Susanne A. Kuhn (2005, 2007, and 2008) and to Rupert Reichart
(2007).
References
Abe K, Kato G, Katafuchi T, Tamae A, Furue H, Yoshimura M (2009)
Responses to 5-HT in morphologically identiWed neurons in the
rat substantia gelatinosa in vitro. Neuroscience 159:316–324.
doi:10.1016/j.neuroscience.2008.12.021
Albrecht MA, Colegrove SI, Hongpaisan J, Pivovarova NB, Andrews
SB, Friel DD (2001) Multiple modes of calcium-induced calcium
release in sympathetic neurons I: attenuation of endoplasmic
reticulum Ca2+ accumulation at low [Ca2+](i) during weak depo-
larization. J Gen Physiol 118(1):83–100. doi:10.1085/jgp.118.
1.83
Anderson CM, Nedergaard M (2003) Astrocyte-mediated control of
cerebral microcirculation. Trends Neurosci 26(7):340–344.
doi:10.1016/S0166-2236(03)00141-3
Baimbridge KG, celio MR, Rogers JH (1992) Calcium-binding
proteins in the nervous system. Trends Neurosci 15(8):303–308.
doi:10.1016/0166-2236(92)90081-I
Barajas M, Andrade A, Hernandez-Hernandez O, Felix R, Arias-Mont-
año JA (2008) Histamine-induced Ca2+ entry in human astrocy-
toma U373 MG cells: evidence for involvement of store-operated
channels. J Neurosci Res 86(15):3456–3468. doi:10.1002/jnr.
21784
Bardo S, Cavazzini MG, Emptage N (2006) The role of the endoplas-
mic reticulum Ca2+ store in the plasticity of central neurons.
Trends Pharmacol Sci 27(2):78–84. doi:10.1016/j.tips.2005.
12.008
Barres BA (2008) The mystery and magic of glia: a perspective on
their roles in health and disease. Neuron 60(3):430–440.
doi:10.1016/j.neuron.2008.10.013
Bender AS, Hertz L (1987) Pharmacological characteristics of
diazepam receptors in neurons and astrocytes in primary cultures.
J Neurosci Res 18(2):366–372. doi:10.1002/jnr.490180215
Bernstein M, Myons SA, Möller T, Kettenmann H (1996) Receptor-
mediated calcium signalling in glial cells from mouse corpus
callosum slices. J Neurosci Res 46(2):152–163. doi:10.1002/(SI-
CI)1097-4547(19961015)46:2<152::AID-JNR3>3.0.CO;2-G
Berridge MJ (2008) Inositol triphosphate and calcium signalling mecha-
nisms. Biochim Biophys Acta. doi:10.1016/j.bbamcr.2008.10.005
Berridge MJ, Bootman MD, Roderick HL (2003a) Calcium signalling:
dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol
4(7):517–529. doi:10.1038/nrm1155
Berridge MJ, Bootman MD, Roderick HL (2003b) Calcium signalling:
dynamics, homeostasis and remodelling. Natl Rev 4:517–529
Blaustein MP, Golovina VA (2001) Structural complexity and func-
tional diversity of endoplasmic reticulum Ca2+ stores. Trends
Neurosci 24(10):602–608. doi:10.1016/S0166-2236(00)01891-9
Bordey A, Feltz P, Trouslard J (1994) Mobilization of intracellular
calcium by substance P in a human astrocytoma cell line (U-
373MG). Glia 11(3):277–283. doi:10.1002/glia.440110309
Castillo CA, Albasanz JL, Fernández M, Martín M (2007) Endogenous
expression of adenosine A1, A2 and A3 receptors in rat C6 glioma
cells. Neurochem Res 32(6):1056–1070. doi:10.1007/s11064-
006-9273-x
Fig. 9 Scheme of putative cal-
cium signaling within the glioma 
cells The Wgure illustrates diVer-
ent pathways of intracellular cal-
cium ion increases, stores as 
well as outXux mechanisms. The 
eVects of calcium signals are for 
higher rates of cellular metabo-
lism, cellular gene transcription 
and protein synthesis, as well as 
proliferation and migration
Ca2+
membrane
depolarization
diffusion
Ca2+
agonist Ca2+ Ca2+
protein synthesis
VGCC
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+ Ca2+
Ca2+ Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
&
metabolism
SOC
ROC
Ca2+ Ca2+
Ca2+
Ca2+
Ca2+
nucleus
Ins(1,4,5)P3R
RyR
Ca2+ Ca2+
Ca2+
Ca2+
Ca2+
Ca2+ Ca2+
Ca2+
Ca2+ Ca2+
Ca2+
Ca2+
+
Ca2+
Ca2+
proliferation
&
motility
Ca2+
ATP
ADP
Ca2+
SERCA
ER/SR
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
ATP
Ca2+
ADP
Na+
Ca2+
Ca2+
Ca2+
K+
Na+
Ca2+
Ca2+
Ca2+
Ca2+
Ca2+
cytoplasm
gene expression1744 J Cancer Res Clin Oncol (2009) 135:1729–1745
123
Chang K, Zhang Lubo (2008) Review article: steroid hormones and
uterine vascular adaptation to pregnancy. Reprod Sci 15(4):336–
348. doi:10.1177/1933719108317975
Clapham DE (2007) Calcium signaling. Cell 131(6):1047–1058.
doi:10.1016/j.cell.2007.11.028
Cooper DM, Caldwell KK, Perez-Reyes E, Ahlijanian MK, Schlegel
W (1988) Interactions between neurotransmitters that regulate
cAMP and intracellular Ca2+ levels in the CNS. Adv Exp Med
Biol 236:217–227
Eistetter HR, Mills A, Brewster R, Alouani S, Rambosson C, Kawashi-
ma E (1992) Functional characterization of neurokinin-1 recep-
tors on human U373MG astrocytoma cells. Glia 6(2):89–95.
doi:10.1002/glia.440060203
Färber K, Kettenmann H (2006) Functional role of calcium signals for
microglial function. Glia 54(7):656–665. doi:10.1002/glia.20412
Fatatis A, Holtzclaw LA, Avidor R, Brennemann DE, Russell JT
(1994) Vasoactive intestinal peptide increases intracellular cal-
cium in astroglia: synergism with alpha-adrenergic receptors.
Proc Natl Acad Sci USA 91(6):2036–2040. doi:10.1073/
pnas.91.6.2036
Friel DD (1995) Calcium oscillations in neurons. Ciba Found Symp
188:210–223
Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA
(2008) Brain metabolism dictates the polarity of astrocyte control
over arterioles. Nature 456(7223):745–749. doi:10.1038/
nature07525
Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+
indicators with greatly improved Xuorescence properties. J Biol
Chem 260(6):3440–3450
Han JZ, Lin W, Lou SJ, Chen YZ (2002) Norepinephrine-induced cal-
cium mobilization in C6 glioma cells. Acta Pharmacol Sin
23(6):490–496
Hegedus E, Kaslin J, Hiripi L, Kiss T, Panula P, Elekes K (2004)
Histaminergic neurons in the central and peripheral nervous sys-
tem of gastropods (Helix, Lymnaea): an immunocytochemical,
biochemical, and electrophysiological approach. J Comp Neurol
475(3):391–405. doi:10.1002/cne.20171
Hernández-Angeles A, Soria-Jasso LE, Ortega A, Arias-Montaño JA
(2001) Histamine H1 receptor activation stimulates mitogenesis
in human astrocytoma U373 MG cells. J Neurooncol 55(2):81–
89. doi:10.1023/A:1013338515229
Hösli L, Hösli E (1987) Receptors for dopamine and serotonin on
astrocytes of cultured rat central nervous system. J Physiol (Paris)
82(4):191–195
Hösli L, Hösli E, Schneider U, Wiget W (1984) Evidence for the exis-
tence of histamine H1- and H2-receptors on astrocytes of cultured
rat central nervous system. Neurosci Lett 48(3):287–291.
doi:10.1016/0304-3940(84)90052-1
Hyde GN, Seale AP, Grau EG, Borski RJ (2004) Cortisol rapidly sup-
presses intracellular calcium and voltage-gated calcium channel
activity in prolactin cells of the tilapia (Oreochromis mossambi-
cus). Am J Physiol Endocrinol Metab 286(4):E626–E633.
doi:10.1152/ajpendo.00088.2003
Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral
microvasculature. Nat Neurosci 10(11):1369–1376. doi:10.1038/
nn2003
Iino M (2008) IdentiWcation of new functions of Ca2+ release from
intracellular stores in central nervous system. Biochem Biophys
Res Commun 369(1):220–224. doi:10.1016/j.bbrc.2007.11.090
Jaiswal JK (2001) Calcium—how and why? J Biosci 26(3):357–363.
doi:10.1007/BF02703745
Putney JW Jr (2007) New molecular players in capacitative Ca2+
entry. J Cell Sci 120(Pt12):1959–1965. doi:10.1242/jcs.03462
Kettenmann H, Backus KH, Schachner M (1984) Aspartate, glutamate
and gamma-aminobutyric acid depolarize cultured astrocytes. Neu-
rosci Lett 52(1–2):25–29. doi:10.1016/0304-3940(84)90345-8
Kirischuk S, Tuschick S, Verkhratsky A, Kettenmann H (1996) Cal-
cium signalling in mouse Bergmann glial cells mediated by
alpha1-adrenoreceptors and H1 histamine receptors. Eur J Neuro-
sci 8(6):1198–1208. doi:10.1111/j.1460-9568.1996.tb01288.x
Labrakakis C, Patt S, Hartmann J, Kettenmann H (1998a) Functional
GABA(A) receptors on human glioma cells. Eur J Neurosci
10(1):231–238. doi:10.1046/j.1460-9568.1998.00036.x
Labrakakis C, Patt S, Hartmann J, Kettenmann H (1998b) Glutamate
receptor activation can trigger electrical activity in human glioma
cells. Eur J Neurosci 10(6):2153–2162. doi:10.1046/j.1460-
9568.1998.00226.x
Gazarczyk M, Matyja E, Lipkowski A (2007) Substance P and its
receptors—a potential target for novel medicines in malignant
brain tumour therapies (mini-review). Folia Neuropathol
45(3):99–107
Lefranc F, Yeaton P, Brotchi J, Kiss R (2006) Cimetidine, an unex-
pected anti-tumor agent, and its potential for the treatment of glio-
blastoma. Int J Oncol 28(5):1021–1030 (review)
Lovick TA, Brown LA, Key BJ (2005) Neuronal activity-related
coupling in cortical arterioles: involvement of astrocyte-derived
factors. Exp Physiol 90(1):131–140. doi:10.1113/expphysiol.
2004.028811
Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis
in human astrocytoma cells correlates with activation of the mito-
gen-activated protein kinase signaling pathway. Cancer Res
56(21):4983–4991
Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H (2007)
Autocrine glutamate signaling promotes glioma cell invasion.
Cancer Res 67(19):9463–9471. doi:10.1158/0008-5472.CAN-
07-2034
Matyash M, Matyash V, Nolte C, Sorrentino V, Kettenmann H (2002)
Requirement of functional ryanodine receptor type 3 for astrocyte
migration. FASEB J 16(1):84–86
McCoy E, Sontheimer H (2007) Expression and function of water
channels (aquaporins) in migrating malignant astrocytes. Glia
55(10):1034–1043. doi:10.1002/glia.20524
Möller T (2002) Calcium signaling in microglial cells. Glia 40(2):184–
194. doi:10.1002/glia.10152
Nielsen FC, Gammeltopf S, Westermark B, Fahrenkrug J (1990) High
aYnity receptors for vasoactive intestinal peptide on a human gli-
oma cell line. Peptides 11(6):1225–1231. doi:10.1016/0196-
9781(90)90156-Y
Olsen ML, Schade S, Lyons SA, Amaral MD, Sontheimer H (2003)
Expression of voltage-gated chloride channels in human glioma
cells. J Neurosci 23(13):5572–5582
Parekh AB (2006) On the activation mechanism of store-operated cal-
cium channels. PXugers Arch 453(3):303–311. doi:10.1007/
s00424-006-0089-y
Parekh AB (2008) Store-operated channels: mechanisms and function.
J Physiol 586(13):3033. doi:10.1113/jphysiol.2008.156885
Parekh AB, Penner R (1997) Store depletion and calcium inXux. Phys-
iol Rev 77(4):901–930
Perea G, Araque A (2005) Glial calcium signaling and neuron-glia
communication. Cell Calcium 38:375–382. doi:10.1016/j.ceca.
2005.06.015
Peters O, Schipke CG, Hashimoto Y, Kettenmann H (2003) DiVerent
mechanisms promote astrocyte Ca2+ waves and spreading
depression in the mouse neocortex. J Neurosci 23(30):9888–9896
Putney JW Jr (1997) Type 3 inositol 1, 4, 5-triphosphate receptor and
capacitative calcium entry. Cell Calcium 21(3):257–261.
doi:10.1016/S0143-4160(97)90050-6
Schipke CG, Boucsein C, Ohlemeyer C, KirchhoV F, Kettenmann H
(2002) Astrocyte Ca2+ waves trigger responses in microglial cells
in brain slices. FASEB J 16(2):255–257
Sharma A, Walters J, Gozes Y, Fridkin M, Brenneman D, Gozes I,
Moody TW (2001) A vasoactive intestinal peptide antagonistJ Cancer Res Clin Oncol (2009) 135:1729–1745 1745
123
inhibits the growth of glioblastoma cells. J Mol Neurosci
17(3):331–339. doi:10.1385/JMN:17:3:331
Sokolowska P, Nowak JZ (2008) EVects of PACAP and VIP on
cAMP-generating system and proliferation of C6 glioma cells. J
Mol Neurosci 36(1–3):286–291. doi:10.1007/s12031-008-9071-9
Sontheimer H (2003) Malignant gliomas: perverting glutamate and ion
homeostasis for selective advantage. Trends Neurosci
26(10):543–549. doi:10.1016/j.tins.2003.08.007
Sontheimer H (2004) Ion channels and amino acid transporters support
the growth and invasion of primary brain tumors. Mol Neurobiol
29(1):61–71. doi:10.1385/MN:29:1:61
Sontheimer H (2008a) An unexpected role for ion channels in brain
tumor metastasis. Exp Biol Med (Maywood) 233(7):779–791.
doi:10.3181/0711-MR-308
Sontheimer H (2008b) A role for glutamate in growth and invasion of
primary brain tumors. J Neurochem 105(2):287–295.
doi:10.1111/j.1471-4159.2008.05301.x
Straub SV, Nelson MT (2007) Astrocytic calcium signaling: the infor-
mation currency coupling neuronal activity to the cerebral micro-
circulation. Trends Cardiovasc Med 17:183–190. doi:10.1016/
j.tcm.2007.05.001
Synowitz M, Ahmann P, Matyash M, Kuhn SA, Hofmann B, Zimmer
C, KirchhoV F, Kiwit JC, Kettenmann H (2001) GABA(A)-recep-
tor expression in glioma cells is triggered by contact with neuro-
nal cells. Eur J Neurosci 14(8):1294–1302. doi:10.1046/j.0953-
816x.2001.01764.x
Verkhratsky A, Shmigol A (1996) Calcium-induced release in neu-
rons. Cell Calcium 19(1):1–14. doi:10.1016/S0143-4160(96)
90009-3
Verkhratsky A, Orkand RK, Kettenmann H (1998) Glial calcium:
homeostasis and signaling function. Physiol Rev 78(1):99–141
Verkhtatsky A, Steinhäuser C (2000) Ion channels in glial cells. Brain
Res Brain Res Rev 32:380–412. doi:10.1016/S0165-0173(99)
00093-4
Weaver AK, Bomben VC, Sontheimer H (2006) Expression and func-
tion of calcium-activated potassium channels in human glioma
cells. Glia 54(3):223–233. doi:10.1002/glia.20364
Weydt P, Möller T, Labrakakis C, Patt S, Kettenmann H (1997) Neu-
roligand-triggered calcium signalling in cultured human glioma
cells. Neurosci Lett 228(2):91–94. doi:10.1016/S0304-3940(97)
00366-2
Wienrich M, Kettenmann H (1989) Activation of substance P receptors
leads to membrane potential responses in cultured astrocytes. Glia
2(3):155–160. doi:10.1002/glia.440020304
Yarowsky PJ, Brougher DS, Krueger BK (1994) Glucocorticoid stim-
ulation of sodium channel expression in cultured astrocytes. Ann
N Y Acad Sci 746:480–484
Zhu L, Luo Y, Chen T, Chen F, Wang T, Hu Q (2008) Ca2+ oscillation
frequency regulates agonist-stimulated gene expression in vascu-
lar endothelial cells. J Cell Sci 121:2511–2518. doi:10.1242/
jcs.031997